Herombopag
Herombopag is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
Herombopag for Chemotherapy-induced Thrombocytopenia
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
Clinical Trials (7)
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
Herombopag for Chemotherapy-induced Thrombocytopenia
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
Herombopag + rhTPO in Severe Immune Thrombocytopenia
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7